S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
Log in
(Ad)
A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

NASDAQ:SLGL - Sol Gel Technologies Stock Price, Forecast & News

$13.99
-0.10 (-0.71 %)
(As of 01/20/2020 03:02 PM ET)
Today's Range
$13.50
Now: $13.99
$14.42
50-Day Range
$8.12
MA: $11.27
$17.15
52-Week Range
$5.71
Now: $13.99
$21.00
Volume40,529 shs
Average Volume258,512 shs
Market Capitalization$264.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.19
Sol-Gel Technologies Ltd., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include TWIN and SIRS-T, which has completed Phase II clinical trials for the treatment of acne vulgaris; and VERED that has completed Phase II clinical trials for the treatment of papulopustular rosacea. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SLGL
CUSIPN/A
Phone972-8931-3429

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$130,000.00
Book Value$3.38 per share

Profitability

Net Income$-32,200,000.00
Net Margins-223.99%

Miscellaneous

EmployeesN/A
Market Cap$264.69 million
Next Earnings Date3/19/2020 (Estimated)
OptionableNot Optionable

Receive SLGL News and Ratings via Email

Sign-up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter.


Sol Gel Technologies (NASDAQ:SLGL) Frequently Asked Questions

What is Sol Gel Technologies' stock symbol?

Sol Gel Technologies trades on the NASDAQ under the ticker symbol "SLGL."

How were Sol Gel Technologies' earnings last quarter?

Sol Gel Technologies Ltd (NASDAQ:SLGL) released its earnings results on Wednesday, November, 13th. The company reported ($0.37) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.12. The company earned $4.73 million during the quarter, compared to analyst estimates of $6.56 million. Sol Gel Technologies had a negative return on equity of 71.98% and a negative net margin of 223.99%. View Sol Gel Technologies' Earnings History.

When is Sol Gel Technologies' next earnings date?

Sol Gel Technologies is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for Sol Gel Technologies.

What price target have analysts set for SLGL?

4 brokerages have issued twelve-month price targets for Sol Gel Technologies' shares. Their forecasts range from $23.00 to $33.00. On average, they anticipate Sol Gel Technologies' share price to reach $26.50 in the next year. This suggests a possible upside of 89.4% from the stock's current price. View Analyst Price Targets for Sol Gel Technologies.

What is the consensus analysts' recommendation for Sol Gel Technologies?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sol Gel Technologies in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sol Gel Technologies.

Has Sol Gel Technologies been receiving favorable news coverage?

Media coverage about SLGL stock has trended somewhat positive on Monday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Sol Gel Technologies earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View News Stories for Sol Gel Technologies.

Are investors shorting Sol Gel Technologies?

Sol Gel Technologies saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 53,800 shares, an increase of 10.5% from the December 15th total of 48,700 shares. Based on an average daily volume of 80,700 shares, the days-to-cover ratio is currently 0.7 days. Currently, 1.4% of the shares of the stock are short sold. View Sol Gel Technologies' Current Options Chain.

Who are some of Sol Gel Technologies' key competitors?

What other stocks do shareholders of Sol Gel Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sol Gel Technologies investors own include Amarin (AMRN), Iovance Biotherapeutics (IOVA), NVIDIA (NVDA), Applied Optoelectronics (AAOI), Adaptimmune Therapeutics (ADAP), Aqua Metals (AQMS), Arena Pharmaceuticals (ARNA), Inovio Pharmaceuticals (INO), Ligand Pharmaceuticals (LGND) and Mylan (MYL).

Who are Sol Gel Technologies' key executives?

Sol Gel Technologies' management team includes the folowing people:
  • Dr. Alon Seri-Levy, Co-Founder, CEO & Director (Age 58)
  • Mr. Gilad Mamlok, Chief Financial Officer (Age 51)
  • Mr. Itzik Yosef, VP of Operations (Age 43)
  • Dr. Ofer Toledano, VP of R&D (Age 54)
  • Dr. Ofra Levy-Hacham Ph.D., VP of Clinical & Regulatory Affairs (Age 53)

When did Sol Gel Technologies IPO?

(SLGL) raised $60 million in an initial public offering (IPO) on Thursday, February 1st 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. ​Jefferies and BMO Capital Markets​ served as the underwriters for the IPO and JMP Securities and Raymond James​ were co-managers.

How do I buy shares of Sol Gel Technologies?

Shares of SLGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Sol Gel Technologies' stock price today?

One share of SLGL stock can currently be purchased for approximately $13.99.

How big of a company is Sol Gel Technologies?

Sol Gel Technologies has a market capitalization of $264.69 million and generates $130,000.00 in revenue each year. The company earns $-32,200,000.00 in net income (profit) each year or ($1.80) on an earnings per share basis. View Additional Information About Sol Gel Technologies.

What is Sol Gel Technologies' official website?

The official website for Sol Gel Technologies is http://www.sol-gel.com/.

How can I contact Sol Gel Technologies?

Sol Gel Technologies' mailing address is 7 GOLDA MEIR ST. WEIZMANN SCIENCE PARK, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-8931-3429 or via email at [email protected]


MarketBeat Community Rating for Sol Gel Technologies (NASDAQ SLGL)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  111 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  242
MarketBeat's community ratings are surveys of what our community members think about Sol Gel Technologies and other stocks. Vote "Outperform" if you believe SLGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: 52-Week Highs and Lows

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel